Currently, I am still undergoing training in Professor You-Me Kim’s laboratory at KAIST, where I am investigating to reveal the novel function of eosinophils and how they are regulated. Cytokines 2023 in Athens marked my second international conference experience. Initially, conversing with foreigners felt incredibly awkward and daunting, but the [READ MORE]
Each year, the International Cytokine & Interferon Society (ICIS) is thrilled to welcome approximately 200 new members, each bringing unique experiences and perspectives that enrich our community. Did you know that you can meet many of these new members in our regular Signals+ feature, New Member Mini-Bios? Reach out, welcome [READ MORE]
When attending Cytokines / KAI 2024, the Local Organizing Committee wants to make sure you experience the best of Seoul. Here are the final two entries in our “Top 10 Must Visit” places in Seoul. Thanks to the Cytokines 2024 LOC member Jae Hun Shin, PhD, Yonsei University, Korea for [READ MORE]
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients (IGNORANT) ClinicalTrials.gov ID NCT05843786 Sponsor Hospices Civils de Lyon Information provided by Hospices Civils de Lyon (Responsible Party) Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) ClinicalTrials.gov ID NCT05535764 Sponsor University [READ MORE]
ICIS is my favorite Society I am involved in, and I am very honored to have received the Amanda Proudfoot Tribute Award for Advances in Chemokine Biology during Cytokines 2023 Conference. This award provides valuable support for my job hunting and encourages me to continue working on cytokines in the [READ MORE]
Join us for Cytokines 2024 / KAI 2024 and be inspired by an exceptional lineup of confirmed speakers. Share your cytokine research with over 2,000 participants from around the world by submitting an abstract for oral or poster presentation by the Abstract Submission and Student Member Travel Award application deadline of May 20, 2024. [READ MORE]
Long time ICIS member, Alberto Mantovani, was recently elected into the National Academy of Sciences (NAS) in recognition of his distinguished achievements in original research. See the May 3 issue of the Signals+ Newsletter for more on that honor. This issue, we’re pleased to feature Prof. Emeritus Mantovani in the [READ MORE]
In the Phase 2 CITYSCAPE trial, Tiragolumab, an anti-TIGIT antibody, demonstrated efficacy when combined with Atezolizumab, an anti-PD-L1, compared to Atezolizumab alone for the treatment of non-small cell lung carcinoma. In mouse models, inhibition of both the TIGIT and PD-1 pathways was shown to synergistically function to reinvigorate T cell [READ MORE]
I am a fan of musical theatre, and scientific meetings definitely have some aspect of performance – just imagine if speakers had to sing their talks? Perhaps a musical about cytokines could be the next hot thing to come to Broadway or the West End? Here are some proposed titles: [READ MORE]
Signals+ Editorial Board member, Maialen Sebastian, recently caught up with a 2023 ICIS-Pfizer Junior Investigator Award recipient, Iolanda Miceli for this interview. “I am concurrently completing my medical degree and scientific training at Monash University Melbourne. I never anticipated that my medical degree would morph into a PhD program as [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
